Results 211 to 220 of about 112,084 (259)

Physiological Signal Entropy in Pediatric Traumatic Brain Injury: Looking Beyond the Obvious: A STARSHIP Study. [PDF]

Crit Care Explor
Bögli SY, Smith CA, Hutchinson P, Agrawal S, Smielewski P, Studying Trends of Autoregulation in Severe Head Injury in Paediatrics (STARSHIP) study team.   +5 more
europepmc   +1 more source

Het ABP-complex

Economisch-statistische berichten, 1995
openaire   +1 more source

Development of an Improved Stacked U-Net Model for Cuffless Blood Pressure Estimation Based on PPG Signals. [PDF]

IEEE Open J Eng Med Biol
Lain JK, Wang CA, Xu JH, Lee CW.
europepmc   +1 more source

Efficacy and Safety of Combined Autologous Blood and Minocycline Pleurodesis for Intractable Pneumothorax in High-Risk Non-Surgical Patients: A Case Series. [PDF]

Respirol Case Rep
Koh E, Sekine Y.
europepmc   +1 more source

ABP Publisher's note

Language and Health
openaire   +1 more source

Early Blood Pressure Targets in Acute Spinal Cord Injury: A Randomized Clinical Trial.

JAMA Netw Open
Sajdeya R, Yanez ND, Kampp M, Goodman MD, Zonies D, Togioka B, Nunn A, Winfield RD, Martin ND, Kohli A, Huynh TT, Okonkwo DO, Poblete RA, Gilmore EJ, Chesnut RM, Bunnell AE, Ohnuma T, Hashemaghaie M, Treggiari MM.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

Journal of Gastroenterology and Hepatology, 2021
There are few clinical data on Adalimumab (ADA) biosimilars in inflammatory bowel disease. We aimed to perform a multicenter, observational, prospective study on safety and effectiveness of ADA biosimilar ABP 501 in patients with inflammatory bowel ...
F. Macaluso, M. Cappello, A. Busacca, W. Fries, A. Viola, G. Costantino, A. Magnano, E. Vinci, C. Ferracane, A. Privitera, G. Piccillo, N. Belluardo, E. Giangreco, C. Romano, M. Citrano, F. Graziano, S. Garufi, C. Bertolami, M. Ventimiglia, B. Scrivo, G. Teresi, S. Renna, G. Rizzuto, A. Casà, A. Orlando   +24 more
semanticscholar   +1 more source

ABP

2022
Dokumentation og vidensdeling af ankesager (ATP og International Pensionsager), direktørklagesager (International Pensionssager) og specialsager (ATP)
openaire   +1 more source

Discrete ABP Estimate and Convergence Rates for Linear Elliptic Equations in Non-divergence Form

Foundations of Computational Mathematics, 2014
We design a two-scale finite element method (FEM) for linear elliptic PDEs in non-divergence form A(x):D2u(x)=f(x)\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy ...
R. Nochetto, Wujun Zhang
semanticscholar   +1 more source

ABP 980: A Trastuzumab Biosimilar

BioDrugs, 2018
ABP 980 (KANJINTI™) is a biosimilar of the reference anti-HER2 antibody trastuzumab. In the EU, ABP 980 is approved for use in all indications for which reference trastuzumab is approved, including HER2-positive early breast cancer, metastatic breast cancer and metastatic gastric cancer.
openaire   +2 more sources